The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 08, 2016

Filed:

Dec. 18, 2014
Applicant:

Shanxi Zhendong Pilot Biological Science and Technology Co., Ltd., Jinzhong, Shanxi, CN;

Inventors:

Weidong Zhang, Shanghai, CN;

Lei Shan, Shanghai, CN;

Juan Su, Shanghai, CN;

Huizi Jin, Shanghai, CN;

Huiliang Li, Shanghai, CN;

Yunheng Shen, Shanghai, CN;

Xike Xu, Shanghai, CN;

Runhui Liu, Shanghai, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 307/00 (2006.01); C07D 307/93 (2006.01); A61K 9/19 (2006.01); A61K 31/365 (2006.01); A61K 36/28 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01);
U.S. Cl.
CPC ...
C07D 307/93 (2013.01); A61K 9/0019 (2013.01); A61K 9/19 (2013.01); A61K 9/2018 (2013.01); A61K 9/2059 (2013.01); A61K 31/365 (2013.01); A61K 36/28 (2013.01); A61K 2236/39 (2013.01);
Abstract

Preparation and application of line leafflower lactone A in the multiple sclerosis, having a structure of Line leafflower lactone A has therapeutic effects on experimental autoimmune encephalomyelitis (EAE) model, and is used to develop drug for treating multiple sclerosis (MS). Line leafflower lactone A drug is a combination containing the active ingredient of line leafflower lactone A and conventional pharmaceutically carrier, and may be in forms of tablets, dispersible tablets, mouth collapse tablets, retard tablets, capsule, soft capsule, dropping pill, granules, injection, powder injection, or aerosol. The pharmaceutical composition is used for treating multiple sclerosis, has tremendous developing potentiality because of its high value of clinical application.


Find Patent Forward Citations

Loading…